Search - tctmd.com

Displaying 1 - 20 of 70

Sort: Relevancy | Date

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

Presentation TCT 2025

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Presenter: Paul Sorajja

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Michael O'Riordan

May 28, 2025

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Caitlin E. Cox

February 14, 2025

Presentation Miami Valves 2025

TMVR and the Tendyne roll-in and MAC experience

Presenter: Pablo Rengifo-Moreno

January 30, 2025

Presentation TCT 2024

TCT 1241: HOCM-Like Physiology Following Tendyne Mitral Valve Repair

Presenter: Safanah Siddiqui

October 30, 2024

Presentation TCT 2024

TCT 940: A Comparative Study of TENDYNE and Traditional Transcatheter Mitral Valve Implantation on Reverse Remodeling and Outcome

Presenter: Chong Bin Lee

October 29, 2024

Presentation TCT 2024

TCT 946: Left Ventricular Volume Predicts In-Hospital Outcome in Tendyne™ Patients

Presenter: Liliane Zillner

October 29, 2024

News Conference News EACTS 2024

AI-Based CT Can Accurately Screen Patients for TMVR

Yael L. Maxwell

October 15, 2024

Presentation NY Valves 2024

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

Presenter: Jason H. Rogers

June 06, 2024

Presentation NY Valves 2024

Compassionate Use Tendyne Transcatheter Mitral Valve Replacement in an ESRD Patient for Severe Calcified Mitral Stenosis and Regurgitation With Complete Resolution of Pulmonary Hypertension Allowing Listing for Renal Transplantation

Presenter: Sukhdeep Singh Basra

June 06, 2024

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

Presentation TCT 2023

TCT 971: First Report of Transeptal Ballon Expandable Valve Implant after Tendyne Degeneration.

Presenter: Paolo Denti

October 24, 2023

Presentation TCT 2023

Tendyne

Presenter: Gorav Ailawadi

October 24, 2023

Presentation TCT 2023

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

Presenter: Jason Rogers

October 24, 2023

Presentation TCT 2023

TCT 925: Left Atrial Appendage Closure (LAAC) in a Patient With Previous Implantation of a Tendyne Valve: “It’s Easier for a Camel to go Through the eye of a Needle…”

Presenter: Guido Ascione

October 24, 2023

Advertisement

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

What’s Going to Be Hot at TCT 2025

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

TMVR and the Tendyne roll-in and MAC experience

TCT 1241: HOCM-Like Physiology Following Tendyne Mitral Valve Repair

TCT 940: A Comparative Study of TENDYNE and Traditional Transcatheter Mitral Valve Implantation on Reverse Remodeling and Outcome

TCT 946: Left Ventricular Volume Predicts In-Hospital Outcome in Tendyne™ Patients

AI-Based CT Can Accurately Screen Patients for TMVR

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

Compassionate Use Tendyne Transcatheter Mitral Valve Replacement in an ESRD Patient for Severe Calcified Mitral Stenosis and Regurgitation With Complete Resolution of Pulmonary Hypertension Allowing Listing for Renal Transplantation

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

TCT 971: First Report of Transeptal Ballon Expandable Valve Implant after Tendyne Degeneration.

Tendyne

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

TCT 925: Left Atrial Appendage Closure (LAAC) in a Patient With Previous Implantation of a Tendyne Valve: “It’s Easier for a Camel to go Through the eye of a Needle…”

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content